Doherty David T. - 05 Mar 2026 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Role
Chief Financial Officer
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Issuer symbol
SGRY
Transactions as of
05 Mar 2026
Net transactions value
-$201,704
Form type
4
Filing time
09 Mar 2026, 19:33:19 UTC
Previous filing
08 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doherty David T Chief Financial Officer C/O SURGERY PARTNERS, INC., 340 SEVEN SPRINGS WAY, SUITE 600, BRENTWOOD /s/ Jennifer Baldock, Attorney-in-Fact 09 Mar 2026 0001908911

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGRY Common Stock Sale $201,704 -14,574 -14% $13.84 88,803 06 Mar 2026 Direct F1, F2
transaction SGRY Common Stock Award +56,697 +64% $14.11* 145,500 05 Mar 2026 Direct F3
transaction SGRY Common Stock Award +54,545 +37% $14.11* 200,045 05 Mar 2026 Direct F4
transaction SGRY Common Stock Award +30,501 +15% $14.11* 230,546 05 Mar 2026 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026.
F2 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.
F4 Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.
F5 Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.